VeriSci specializes in electrophysiological devices for assessment of visual
function. The Neucodia system (FDA cleared) integrates cutting-edge technologies, superior engineering, and protocols for
the latest scientific discoveries in the field. Currently, VeriSci is involved in clinical testing in collaboration with leading
universities and hospitals across the U.S. to advance novel electrophysiological applications in the clinic. Our newest model
of the device can be configured for a variety of applications that involve visual disorders including early-stage glaucoma, amblyopia, diabetic retinopathy and other
neurological disorders. Check our Product section for more information.
VeriSci’s mission is to become a world leader in providing
quality medical equipment for diagnosis, screening, research and monitoring of sensori-neural disorders.